Where does Cumberland Pharmaceuticals Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cumberland Pharmaceuticals Inc. ranks #12,396 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cumberland Pharmaceuticals Inc. hold?

Cumberland Pharmaceuticals Inc. holds 24 US utility patents granted between 2015 and 2024, spanning 5 technology areas.

What is Cumberland Pharmaceuticals Inc.'s Innovation Score?

Cumberland Pharmaceuticals Inc. has an Innovation Score of 32.6 out of 100 (42nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cumberland Pharmaceuticals Inc. focus on?

Cumberland Pharmaceuticals Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 24 patents, ranking #816 of 6,058 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Cumberland Pharmaceuticals Inc.'s patent grant rate increasing or decreasing?

Cumberland Pharmaceuticals Inc.'s recent grant velocity is -67% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cumberland Pharmaceuticals Inc.'s patents?

Cumberland Pharmaceuticals Inc.'s patents average 16.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cumberland Pharmaceuticals Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cumberland Pharmaceuticals Inc.

USPTO PatentsView assignee record - 24 granted patents across 5 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cumberland ranks #12,396 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 5 technology areas.

#12,396
of 49,997 US assignees by volume: 42nd percentile
by Innovation Score (32.6/100): 16.0
avg claims per patent: -67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12396 · US Corporation #12,396 · 24 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 24 grants
UPPER-Q #12,396/49,997
PHOTO-FINISH Comcast Cable Holdings
CPC-NARROW A61P · 5 areas
INNOV-THIN 32.6/100
CLAIMS-RICH 16.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Comcast Cable Holdings, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cumberland’s 32.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.1 pts (34%) Velocity 4.0 pts (12%) Breadth 7.9 pts (24%) Claim depth 9.6 pts (29%)

Qualcomm Incorporated · highest

85
Cumberland Pharmaceu… · this assignee

33
3D Lighting… · lowest

7

What this shows Cumberland's Innovation Score is 32.6/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cumberland?

Each dot is one of Cumberland’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cumberland’s own 16.0 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cumberland vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cumberland's grants concentrate

Cumberland Pharmaceuticals Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (7 grants) versus a trough of 1 in 2021. By volume, Cumberland sits between Comcast Cable Holdings, LLC and Deka Biosciences, Inc..

Cumberland's three-year grant acceleration

Cumberland Pharmaceuticals Inc. shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Comcast Cable Hol…

24
Cortec

24
for National Rese…

24
Coviden

24
Cyclerion Therape…

24
Cyral

24
D-link

24
Deka Biosciences

24
Cumberland Pharma… ◀

24

What this shows Cumberland holds 24 patents at rank #12,398, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cumberland

By rank, the assignees closest to #12,398 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Cumberland's primary technology class.

Cumberland's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 42nd percentile higher than 42% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cumberland Pharmaceuticals Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	29.2%
2016	3	12.5%
2017	3	12.5%
2018	3	12.5%
2019	2	8.3%
2020	2	8.3%
2021	1	4.2%
2023	2	8.3%
2024	1	4.2%

Which technologies does Cumberland Pharmaceuticals Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 24

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 24

C07D - Heterocyclic Compounds 6

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 3

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cumberland Pharmaceuticals Inc.'s patent record in context - here's where to go next.

Cumberland Pharmaceuticals Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #12,396 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cumberland Pharmaceuticals Inc. against Comcast Cable Holdings, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.